WellSpan Health and Royal Philips have announced a landmark seven-year strategic alliance aimed at accelerating innovation and research across Central Pennsylvania and Northern Maryland. This collaboration places WellSpan at the forefront of diagnostics and imaging in community health through a groundbreaking research and innovation strategy designed to shape the future of care delivery.
Details of the Alliance
The strategic alliance, announced on June 4, 2026, establishes a new research and innovation collaboration between WellSpan Health and Philips. It brings advanced imaging and diagnostics technology products and platforms to patients across the region. This partnership is the latest addition to WellSpan’s growing innovation ecosystem, positioning the system as a national leader in the application of artificial intelligence and technology in healthcare.
Key Components
The collaboration includes a research agreement and joint innovation strategy, the first of its kind between Philips and a U.S. community health system. This will focus on validating the performance of new tools and technology. Research is expected to examine how AI and digital tools improve throughput, cost, and workflow efficiency, aimed at advancing WellSpan’s commitment to reclaim more than half a million hours of workforce time annually.
Additionally, the innovation component allows WellSpan, together with Philips Research, to co-develop new products and features that advance care delivery. This work will draw on Philips’ R&D pipeline to design and develop future generations of healthcare technology, with WellSpan serving as both a proving ground and a co-creator.
Commercial Agreement
A long-term commercial agreement establishes Philips as WellSpan’s preferred vendor across all applicable imaging modalities, including CT, MR, digital X-ray, ultrasound, and image-guided therapy. The agreement covers all 12 WellSpan hospitals, as well as its diagnostic imaging centers and ambulatory surgery centers, ensuring a consistent experience for patients wherever they need care. A defining feature of the commercial agreement is its structured approach to technology lifecycle management: WellSpan and Philips will align equipment, service, training, and upgrade planning under a single coordinated framework, enabling more consistent imaging availability across sites, reducing gaps in access for patients, and laying the foundation for continued innovation.
Leadership Perspectives
“As WellSpan has grown in clinical capability, so has our responsibility to be more intentional about how we plan, deploy and support the life-saving technology our teams and patients rely on,” said Roxanna Gapstur, Ph.D., R.N., WellSpan president and CEO. “This collaboration gives us that foundation, bringing consistency and coordination across our entire system, advancing digital and AI-enabled care and building a leading research and co-development platform that will transform the future of health care. Community health systems like WellSpan are where most Americans receive care, and we are proving they belong at the center of health care innovation.”
